Harmonix

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, focused on developing a 3D augmented reality holographic platform aimed at enhancing interventional medical procedures. Incorporated in 2017 and originating from Washington University, SentiAR's technology allows for real-time holographic visualization of a patient's anatomy and catheter positioning during procedures, utilizing data from various imaging modalities such as CT and MRI. This innovative platform is designed to create an interactive and controllable interface for clinicians, thereby improving the accuracy and safety of cardiac arrhythmia treatments. SentiAR's mission is to significantly enhance the experience for both patients and healthcare providers in catheter lab environments. The company is currently working towards obtaining FDA approval for its platform.

ATLAS Space Operations, Inc. is a company focused on transforming satellite communications and data management. Founded in 2015 and headquartered in Traverse City, Michigan, ATLAS develops the ATLAS Freedom Software Platform, a cloud-based system that enables users to efficiently gather and analyze information from space. This innovative platform features flexible scheduling, cloud processing, and a global network of antennas, allowing clients to optimize their satellite communications at a lower cost. By leveraging advanced technology and a unique approach to space-based communications, ATLAS aims to provide more accessible and scalable solutions for organizations engaged in satellite operations.

Attivare Therapeutics is focused on developing innovative biomaterial vaccines and immuno-therapeutics aimed at treating tumors characterized by low immunogenicity. The company's technology creates a unique physical microenvironment within the body that concentrates immune cells, while also delivering immunomodulatory agents to these cells. This approach is designed to effectively reprogram the immune response and overcome tolerance to cancer antigens. By enabling research scientists to develop bioactive components, Attivare Therapeutics seeks to significantly enhance both the magnitude and durability of immune responses in patients, thereby advancing the field of cancer immunotherapy.

Sorcero, Inc. is a technology company founded in 2017 and headquartered in Washington, D.C. It specializes in developing a no-code platform that utilizes artificial intelligence to support decision-making and knowledge management for professionals in STEM fields, particularly in medical, insurance, and engineering industries. The Sorcero Language Intelligence Platform empowers subject matter experts by enabling the deployment of intelligent applications that can analyze and interpret complex data effectively. This platform is designed to enhance various operational processes, such as medical claims investigation, life insurance underwriting, and real-time monitoring of medical guidelines. Sorcero has received notable recognition within the digital health and insurtech sectors, being acknowledged as a leading startup by industry innovation leaders. The company's focus on improving patient outcomes and providing strategic insights through advanced analytics positions it as a significant player in the life sciences and medical analytics landscape.

xCures, Inc. is a healthcare technology company founded in 2018 and based in Los Altos, California, focused on transforming cancer treatment through its innovative AI-based precision oncology platform. The company addresses the challenges of traditional drug-centric treatment development by integrating cancer research and patient care. Its platform operates as a perpetual trial, continuously capturing Real World Evidence (RWE) from patients and treatments, allowing for real-time learning and adaptation. By coordinating treatment recommendations across various institutions, xCures ensures that patients receive personalized treatment options tailored to their specific needs. Additionally, the platform organizes insights from tumor boards, leveraging machine learning to assist healthcare professionals in making informed decisions. This approach not only enhances the effectiveness of cancer care but also aims to reduce the time and cost associated with drug development, ultimately improving patient outcomes.

Strateos specializes in automating chemistry, biology, and tissue analysis in closed-loop robotic labs, accelerating drug discovery programs for pharmaceutical partners. By combining advanced robotics, software for imaging and analytics, and remote cloud laboratories, Strateos enables more rapid and efficient discovery of new drug candidates. The company was formed through a merger of Transcriptic, which developed the first robotic cloud laboratory platform for life science research, and 3Scan, which specialized in automating tissue analysis. Strateos aims to express life science methods as data, enabling infrastructure virtualization and driving the next generation of discovery with significant time and cost efficiencies.

Sana Health, Inc. is a digital health company based in Lafayette, Colorado, with an additional office in Mill Valley, California. Founded in 2015, the company specializes in developing bio-therapeutic devices designed to promote relaxation and alleviate pain and tension. Its flagship product, Sana, is a non-addictive mask and headphone combination that utilizes audiovisual stimulation to enhance the balance between the left and right sides of the brain, facilitating a deep meditative state. This device employs coordinated pulses of light and sound to guide users into relaxation, mimicking the benefits of long-term meditation practices. Sana Health is also engaged in multiple clinical studies, focusing on applications for conditions such as fibromyalgia and neuropathic pain, as well as trials related to anxiety and PTSD. The company offers its products for sale online and provides a mobile application accessible via major app platforms.

Scribe Biosciences specializes in developing single-cell analysis tools for both clinical and research applications. The company utilizes Printed Droplet Microfluidics (PDM), a technology that allows for precise manipulation of fluids at the picoliter scale. This system employs fluorescence-activated microfluidic droplet sorting and a specialized substrate to handle individual cells and fluid samples with high throughput, enabling detailed studies in areas such as infectious diseases and cancer research.

Scribe Biosciences specializes in developing single-cell analysis tools for both clinical and research applications. The company utilizes Printed Droplet Microfluidics (PDM), a technology that allows for precise manipulation of fluids at the picoliter scale. This system employs fluorescence-activated microfluidic droplet sorting and a specialized substrate to handle individual cells and fluid samples with high throughput, enabling detailed studies in areas such as infectious diseases and cancer research.

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, focused on developing a 3D augmented reality holographic platform aimed at enhancing interventional medical procedures. Incorporated in 2017 and originating from Washington University, SentiAR's technology allows for real-time holographic visualization of a patient's anatomy and catheter positioning during procedures, utilizing data from various imaging modalities such as CT and MRI. This innovative platform is designed to create an interactive and controllable interface for clinicians, thereby improving the accuracy and safety of cardiac arrhythmia treatments. SentiAR's mission is to significantly enhance the experience for both patients and healthcare providers in catheter lab environments. The company is currently working towards obtaining FDA approval for its platform.

ATLAS Space Operations, Inc. is a company focused on transforming satellite communications and data management. Founded in 2015 and headquartered in Traverse City, Michigan, ATLAS develops the ATLAS Freedom Software Platform, a cloud-based system that enables users to efficiently gather and analyze information from space. This innovative platform features flexible scheduling, cloud processing, and a global network of antennas, allowing clients to optimize their satellite communications at a lower cost. By leveraging advanced technology and a unique approach to space-based communications, ATLAS aims to provide more accessible and scalable solutions for organizations engaged in satellite operations.

Visicell Medical is a company focused on advancing stem cell-based therapies by developing safe and biodegradable tracking tools for stem cells. These innovative tools allow for real-time monitoring of injected stem cells in patients, facilitating both clinical and pre-clinical applications. Additionally, Visicell Medical specializes in medical imaging technology that enhances the early detection and diagnosis of diseases. The company offers specialized image capture systems and analysis tools that provide high-resolution, three-dimensional views of tissues or cells, enabling medical professionals to detect abnormalities with greater accuracy. This capability supports earlier interventions and improved treatment outcomes, potentially lowering overall healthcare costs.

Aether Bio is a technology company that focuses on re-purposing enzymes to create new compounds using machine learning. By integrating machine learning with high-throughput robotic laboratories, Aether Bio engineers enzymes rapidly and enables massively parallelized experimentation. This innovative approach generates significantly larger datasets compared to competitors, allowing researchers to manufacture complex and novel products more efficiently and at a lower cost. The company's technology aims to provide healthcare institutions with sustainable and affordable chemicals and materials essential for their operations.

Trials.ai is a technology company based in San Diego, California, specializing in the optimization of clinical trials through its innovative platform. Founded in 2015, the company offers a comprehensive system that integrates various functionalities, including electronic data capture, clinical trial management, patient-reported outcomes, and analytics, all designed to streamline trial management. By leveraging artificial intelligence, Trials.ai assists pharmaceutical, biotech, and medical device companies in designing efficient clinical trials, ultimately reducing the time and costs associated with bringing new treatments to market. The platform addresses challenges such as patient eligibility, visit management, and protocol adherence, guiding both researchers and patients through the trial process. Additionally, Trials.ai taps into vast amounts of previously underutilized data, providing unique insights and recommendations to trial sponsors for optimizing their trial protocols. This approach aims to enhance the success rate of clinical trials and ensure that effective treatments reach patients more quickly.

Qu Biologics Inc., founded in 2007 and based in Burnaby, Canada, specializes in developing immunotherapies aimed at restoring normal immune function. The company's primary focus is on Site Specific Immunomodulators (SSIs), which are designed to activate the body’s immune system to combat chronic inflammation associated with various conditions, including cancer and inflammatory bowel disease (IBD). Qu Biologics has treated over 270 patients with advanced cancer and moderate-to-severe immune-related diseases through a compassionate use program, showing promising preliminary outcomes. The company is currently recruiting for a Phase 1/2 clinical trial in Crohn’s disease, with the goal of improving survival rates and quality of life for individuals affected by cancer and debilitating immune-related diseases such as ulcerative colitis and rheumatoid arthritis.

Pathology Watch Inc. is a company that specializes in providing remote specimen interpretation services through its digital pathology solution, primarily for hospitals, laboratories, and dermatology centers. Founded in 2017 and headquartered in Salt Lake City, Utah, the company collaborates with dermatopathologists and subspecialized pathologists to interpret digital slides, pathology reports, and biopsy slides. By digitizing the pathology workflow, Pathology Watch enhances the quality of patient care while reducing costs and creating new revenue opportunities for clinical practices. Additionally, the company offers telepathology services tailored for large clinics and hospitals, ensuring efficient and effective pathology services.

Halo Industries, Inc. is a technology company based in San Mateo, California, focused on enhancing the energy output of solar thermal systems through innovative solutions. Established in 2014, it specializes in developing laser-based hardware systems that facilitate materials processing across various industries, including solar, semiconductors, LEDs, batteries, and power electronics. The company's automated production line tools aim to reduce costs while improving operational efficiency and product quality, supporting the advancement of next-generation technologies in these sectors.

xCures, Inc. is a healthcare technology company founded in 2018 and based in Los Altos, California, focused on transforming cancer treatment through its innovative AI-based precision oncology platform. The company addresses the challenges of traditional drug-centric treatment development by integrating cancer research and patient care. Its platform operates as a perpetual trial, continuously capturing Real World Evidence (RWE) from patients and treatments, allowing for real-time learning and adaptation. By coordinating treatment recommendations across various institutions, xCures ensures that patients receive personalized treatment options tailored to their specific needs. Additionally, the platform organizes insights from tumor boards, leveraging machine learning to assist healthcare professionals in making informed decisions. This approach not only enhances the effectiveness of cancer care but also aims to reduce the time and cost associated with drug development, ultimately improving patient outcomes.

Auransa Inc. is a clinical stage drug development company founded in 2014 and based in Palo Alto, California. The company focuses on inventing novel drugs for challenging diseases, including cancer, autoimmune disorders, and neurological conditions, utilizing its proprietary AI-driven drug discovery platform. This platform enables Auransa to analyze extensive genomics data from human disease tissues, facilitating the study of molecular disease subtypes and the prediction of effective compounds and targets for specific patient populations. Auransa's current pipeline includes a first-in-class investigational new drug for cancer that is undergoing clinical trials. Additionally, the company collaborates with various partners in the biopharma industry to enhance its research and development efforts.

Rad AI, Inc. is a technology company based in Berkeley, California, specializing in artificial intelligence solutions for radiologists. Established in 2018, it has developed an automated report generation platform designed to streamline the radiology workflow. This platform enables radiologists to automate repetitive tasks, such as generating report impressions and dictating findings through voice recognition technology. Additionally, it assists in identifying errors and significant findings, automatically inserting customizable recommendation macros, and providing comprehensive answers to ordering clinicians. By integrating seamlessly into existing workflows, Rad AI enhances efficiency and accuracy, ultimately helping to alleviate burnout for radiologists and improve overall patient care.

Sana Health, Inc. is a digital health company based in Lafayette, Colorado, with an additional office in Mill Valley, California. Founded in 2015, the company specializes in developing bio-therapeutic devices designed to promote relaxation and alleviate pain and tension. Its flagship product, Sana, is a non-addictive mask and headphone combination that utilizes audiovisual stimulation to enhance the balance between the left and right sides of the brain, facilitating a deep meditative state. This device employs coordinated pulses of light and sound to guide users into relaxation, mimicking the benefits of long-term meditation practices. Sana Health is also engaged in multiple clinical studies, focusing on applications for conditions such as fibromyalgia and neuropathic pain, as well as trials related to anxiety and PTSD. The company offers its products for sale online and provides a mobile application accessible via major app platforms.

Volumetric, Inc. is an advanced biomaterials and biofabrication company based in Houston, Texas, established in 2014. It specializes in developing a 3D bioprinting platform designed to create vascularized human tissue, which can be utilized in various applications such as life sciences, drug discovery, and medical devices. The company offers bioprinters and bioinks that aim to facilitate innovations in biomaterials, cancer research, and the potential replacement of human organs. By focusing on creating materials embedded with living cells, Volumetric is at the forefront of integrating cutting-edge technology into healthcare solutions.

Ancilia Biosciences is a biotechnology company focused on developing engineered bacterial therapies aimed at treating diseases associated with the microbiome. The company specializes in creating virus-resistant live bacterial products that modulate the human microbiome, specifically targeting the viral components of the gut microbiome. By concentrating on enhancing healthy gut bacteria and their predatory phages, Ancilia develops therapeutic strains that can effectively combat chronic diseases in the fields of immunology and oncology. Additionally, the company is pioneering a new class of live biotherapeutics that allow for the precise targeting of phages or viruses known to induce lysis, thereby advancing treatment options in microbiome-related health conditions.

GEn1E Lifesciences Inc. is a biotechnology company based in Palo Alto, California, that focuses on developing therapies for inflammatory and age-related diseases. Incorporated in 2018, GEn1E employs a unique artificial intelligence platform to accelerate the creation of immunomodulatory therapies targeted at rare diseases that currently lack effective treatments. The company has built a robust pipeline of over 21 novel immunomodulators and is working to expedite the development of additional therapies to address pressing health challenges. One of its key products, MUC1-ED, is an antibacterial therapy designed to combat pseudomonas infections. GEn1E's innovative approach allows for the rapid advancement of drug development, significantly reducing time and costs compared to traditional methods in the pharmaceutical industry. The company's experienced team, formed from notable backgrounds in drug development and machine learning, has made substantial progress in a short period, with the aim of delivering life-saving treatments to patients in need.

Juvena Therapeutics, Inc. is a biopharmaceutical company based in San Mateo, California, founded in 2017. The company focuses on developing protein-based therapeutics aimed at promoting tissue rejuvenation, primarily targeting age-related conditions such as sarcopenia, wound healing, and neural regeneration. Juvena Therapeutics utilizes a drug discovery platform that screens for restored cellular functions to create innovative therapeutics that facilitate tissue regeneration and repair. By decoding secreted proteins, the company aims to address various chronic and rare diseases, ultimately enhancing the quality of life for elderly patients.

Bioz Inc. is a technology company based in Palo Alto, California, specializing in cloud-based applications that utilize natural language processing (NLP) to aid scientific researchers. Established in 2013, Bioz operates a platform that serves as a search engine specifically for life science experimentation, allowing researchers in academia and biopharma to efficiently identify and compare reagents, instruments, and consumables for their experiments. The platform employs advanced AI to analyze data from the materials and methods sections of peer-reviewed articles, providing relevancy rankings, product ratings, and collaborative insights. By streamlining the process of finding and selecting appropriate scientific products, Bioz aims to accelerate drug discovery and enhance the success rate of finding cures for various diseases.

Pragma Bio is a biotechnology company that focuses on developing microbiome-based therapeutics for cancer and autoimmune diseases. Founded in 2018 in Millbrae, California, by Peter McCaffrey, Kovi Bessoff, Ayin Vala, and Kareem Barghouti, the company utilizes proprietary genomic sequencing, artificial intelligence, and synthetic biology techniques to discover biomarkers and therapeutics for complex immunologic disorders. Pragma Bio's platform aggregates both public and private data to create a comprehensive microbiome database, enhancing the ability to identify connections between diverse biological data. This approach not only aids in the discovery of novel biomarkers for patient risk stratification and clinical outcome prediction but also enables the identification of small molecules derived from human-associated bacteria. By leveraging real-world data and advanced analytical processes, Pragma Bio aims to streamline drug discovery and deliver innovative medicines more efficiently and cost-effectively, particularly in relation to the gut-immune axis.

Viscient Biosciences is a biotechnology company based in San Diego, California, founded in 2017 by former scientists and entrepreneurs from Organovo and Ardea Biosciences. The company specializes in drug discovery and development using human 3D tissue technology combined with multi-omics analysis, which includes genomics, transcriptomics, and metabolomics. This approach allows Viscient to identify genes and pathways that drive disease progression, initially focusing on non-alcoholic steatohepatitis (NASH), commonly known as fatty liver disease. By leveraging this innovative platform, Viscient aims to revolutionize drug discovery beyond traditional animal models.

Nelumbo Inc. is a materials innovation company based in Menlo Park, California, founded in 2015. It specializes in manufacturing thin superomniphobic nanocoatings designed for air conditioning cooling coil fins and refrigeration units. The company's key products include Ice-Nein, which helps prevent frost buildup on refrigeration equipment, thereby reducing defrosting downtime, and Omniphobe, which enhances the efficiency of cooling coils in air conditioning systems. Nelumbo focuses on developing advanced heat exchangers for the heating, ventilation, and air conditioning (HVAC) market, aiming to improve energy performance while minimizing corrosion. Through its innovative approach, the company seeks to address significant opportunities for reducing carbon emissions and energy consumption on a global scale.

ATLAS Space Operations, Inc. is a company focused on transforming satellite communications and data management. Founded in 2015 and headquartered in Traverse City, Michigan, ATLAS develops the ATLAS Freedom Software Platform, a cloud-based system that enables users to efficiently gather and analyze information from space. This innovative platform features flexible scheduling, cloud processing, and a global network of antennas, allowing clients to optimize their satellite communications at a lower cost. By leveraging advanced technology and a unique approach to space-based communications, ATLAS aims to provide more accessible and scalable solutions for organizations engaged in satellite operations.

Prime Movers Lab, established in 2018 and headquartered in Jackson, Wyoming, is a venture capital firm focusing on early-stage investments in deep technology companies. It primarily invests in sectors such as energy, transportation, infrastructure, manufacturing, and agriculture, seeking to support startups that are reinventing these industries. The firm typically invests between $0.25 million and $5 million in equity, without taking board seats or acquiring controlling stakes. It does not lead investments, make co-investments, or invest in publicly listed securities. Prime Movers Lab provides comprehensive resources and integrated coaching to its portfolio companies, leveraging in-depth academic research, commercialized intellectual property, and mentorship from renowned scientists to enhance their chances of success.

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, focused on developing a 3D augmented reality holographic platform aimed at enhancing interventional medical procedures. Incorporated in 2017 and originating from Washington University, SentiAR's technology allows for real-time holographic visualization of a patient's anatomy and catheter positioning during procedures, utilizing data from various imaging modalities such as CT and MRI. This innovative platform is designed to create an interactive and controllable interface for clinicians, thereby improving the accuracy and safety of cardiac arrhythmia treatments. SentiAR's mission is to significantly enhance the experience for both patients and healthcare providers in catheter lab environments. The company is currently working towards obtaining FDA approval for its platform.

Halo Industries, Inc. is a technology company based in San Mateo, California, focused on enhancing the energy output of solar thermal systems through innovative solutions. Established in 2014, it specializes in developing laser-based hardware systems that facilitate materials processing across various industries, including solar, semiconductors, LEDs, batteries, and power electronics. The company's automated production line tools aim to reduce costs while improving operational efficiency and product quality, supporting the advancement of next-generation technologies in these sectors.

Abalone Bio, Inc. is a biotechnology company based in Richmond, California, founded in 2017. The company specializes in the development of antibody drugs aimed at treating a range of conditions, including pain, inflammatory diseases, rare cancers, and rare kidney diseases. Abalone Bio utilizes libraries of yeast cells that express various antibody variants to create recombinant protein versions of its antibodies. This innovative approach allows the company to effectively activate or inhibit drug targets, confirming their efficacy through human cell assays. By focusing on unlocking new disease treatments, particularly for peripheral neuropathy and other rare diseases, Abalone Bio aims to advance the field of medicine through the integration of gene sequencing and synthetic biology.

Tarana Wireless, Inc. is a technology company that specializes in researching, developing, and commercializing non-line-of-sight (NLoS) wireless transport solutions. Its flagship product, AbsoluteAir 2, offers advanced wireless transport capabilities with features such as deterministic True NLOS performance, extensive coverage, multi-kilometer range, and high spectral efficiency. The company provides construction-grade installation services and a carrier-class management system that allows operators to configure, monitor, and manage their network nodes effectively. Tarana's solutions are designed to support various applications, including small-cell backhaul, wireless fiber extension, and fixed wireless broadband access. The company serves tier-1 telecommunications operators globally and is headquartered in Milpitas, California, with additional offices in Berkeley, California, and Pune, India. Tarana Wireless was established in 2009 and has made significant advancements in wireless technology, offering lower total cost of ownership and unmatched scalability for its clients.

DermaSensor, Inc. is a Miami-based company that specializes in developing innovative technology for skin cancer evaluation. Founded in 2009, the company has created a handheld device that employs artificial intelligence, machine learning, and elastic scattering spectroscopy to assess skin lesions for potential cancer. This device enables both physicians and consumers to perform skin checks in various settings, including clinics and at home. By providing an efficient and affordable solution for early skin cancer detection, DermaSensor aims to improve access to vital healthcare services and reduce the costs associated with skin cancer diagnosis. The technology not only identifies cancerous cells but also sends alerts when such cells are detected, facilitating timely intervention.

Mathison is a technology company that specializes in diversity hiring and retention solutions. Its platform provides an all-inclusive system for organizations to enhance their diversity, equity, and inclusion (DEI) strategies. This includes tools for sourcing underrepresented candidates, reducing bias in hiring processes, and fostering organizational engagement around diversity initiatives. Mathison's offerings enable companies to manage and measure their DEI efforts effectively while ensuring personalized job opportunities for candidates, all while maintaining their privacy. The platform serves as a recruitment marketplace, centralizing talent networks to facilitate connections between employers and candidates. Mathison collaborates with a variety of prominent brands, enhancing their hiring practices and commitment to diversity.

Terramera, founded in 2009 and based in Vancouver, Canada, specializes in developing and manufacturing plant-based pesticides and fertilizers as alternatives to conventional chemical products. The company offers solutions such as Proof for bed bug and dust mite control, Actigate as an organic pesticide, and Rango for pest control and crop protection. Terramera's technology platforms integrate artificial intelligence, science, and nature to promote sustainable farming practices, aiming to create a healthy and safe environment free from toxic chemicals. This approach supports farmers in achieving improved yields and profits through organic and sustainable methods.

REITIUM is a real estate marketplace that democratizes access to property investment, allowing individuals to become real estate investors with as little as $100. Targeting a diverse audience, including millennials, seniors, and residents of developing countries, the platform aims to unlock the potential of approximately $3 trillion in untapped capital. Utilizing blockchain technology, REITIUM simplifies the investment process by eliminating traditional barriers, enabling users to securely invest in global real estate assets. Users can easily create an account, fund their wallets, browse available properties, and enjoy the benefits of fractional ownership, which includes sharing in rental income and property appreciation. This innovative approach allows investors to grow their wealth and provides the flexibility to sell their investments at any time.

Unlimited Tomorrow, Inc. is a company focused on developing advanced prosthetic technologies for amputees, utilizing 3D scanning, 3D printing, and machine learning. Founded in 2014 and based in Rhinebeck, New York, the company creates robotic arms and legs that can be controlled through the user's thoughts. By employing 3D scanners to digitally map an amputee's residual limb and the opposite full arm, Unlimited Tomorrow tailors each artificial limb to fit the individual precisely. Their open-source approach aims to make these cutting-edge technologies accessible and affordable, particularly for individuals in remote and underprivileged communities who may otherwise lack access to prosthetic solutions. The company's commitment to prioritizing user needs ensures that its innovations effectively cater to the diverse requirements of differently-abled individuals.

Upward Farms is an innovative indoor aquaponic farm that specializes in cultivating leafy greens and fish while adhering to high ecological and quality standards. By integrating modern vertical farming techniques with the ancient practice of aquaponics, the company creates a self-sustaining ecosystem where fish naturally fertilize the crops. This method allows Upward Farms to produce USDA-certified organic microgreens and hybrid striped bass without the use of antibiotics, hormones, or mercury. The result is a range of convenient, local, and ready-to-eat food products designed to nourish people, families, and the planet while promoting sustainability.

Upward Farms is an innovative indoor aquaponic farm that specializes in cultivating leafy greens and fish while adhering to high ecological and quality standards. By integrating modern vertical farming techniques with the ancient practice of aquaponics, the company creates a self-sustaining ecosystem where fish naturally fertilize the crops. This method allows Upward Farms to produce USDA-certified organic microgreens and hybrid striped bass without the use of antibiotics, hormones, or mercury. The result is a range of convenient, local, and ready-to-eat food products designed to nourish people, families, and the planet while promoting sustainability.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Momentus Inc. is a commercial space company based in Santa Clara, California, founded in 2017. The company specializes in providing water-powered transportation services for spacecraft, focusing on in-space infrastructure. Momentus offers a range of services, including space transportation, hosted payloads, and in-orbit servicing, utilizing innovative water plasma-based propulsion technology that is currently under development. Its transfer and service vehicles are designed to carry satellites and hosted payloads between different orbits, supporting the growing demands of the new space economy.

Babylon Micro-Farms Inc. is a company that specializes in providing innovative indoor farming solutions, enabling clients to cultivate their own produce, including leafy greens, herbs, microgreens, and edible flowers. Founded in 2017 and based in Charlottesville, Virginia, Babylon Micro-Farms has developed a smart, scalable indoor farming platform that simplifies the growing process. Utilizing remote management technology, the company aims to create a distributed network of micro-farms across North America, making sustainable hydroponic farming more accessible. The design includes low-cost micro-farms that not only cater to individual consumers but also address food insecurity, particularly in regions such as the Middle East. By automating complex farming processes, Babylon Micro-Farms empowers communities to grow fresh produce year-round while minimizing water usage, food waste, and environmental pollutants.

Prime Movers Lab, established in 2018 and headquartered in Jackson, Wyoming, is a venture capital firm focusing on early-stage investments in deep technology companies. It primarily invests in sectors such as energy, transportation, infrastructure, manufacturing, and agriculture, seeking to support startups that are reinventing these industries. The firm typically invests between $0.25 million and $5 million in equity, without taking board seats or acquiring controlling stakes. It does not lead investments, make co-investments, or invest in publicly listed securities. Prime Movers Lab provides comprehensive resources and integrated coaching to its portfolio companies, leveraging in-depth academic research, commercialized intellectual property, and mentorship from renowned scientists to enhance their chances of success.

PolySpectra, Inc. is a Berkeley, California-based company founded in 2016 that specializes in the development of computer-guided 3-D printing resins. The company focuses on transforming 3D printing from a prototyping tool into a viable production manufacturing solution. PolySpectra manufactures functional materials for advanced additive manufacturing, utilizing light-activated catalysts to create durable plastic parts suitable for consumer use. Its modular platform allows for the delivery of materials with a wide range of tailored properties derived from a single chemical system. This innovative approach supports inventors, designers, and engineers in bringing their concepts to life.

Partsium is a B2B market place that facilitates the commercialization of automotive parts.

Amaz Project offers energy drinks that include yerba mate, green tea, guarana, acerola berries, suma root, and yanomami mushrooms. They sell their products online. The company's contact modes are mail and physical address.

PreciPoint GmbH is a leading provider of digital microscopy solutions, specializing in the design, development, and manufacturing of advanced digital microscopes and associated software. Founded in 1982 and based in Freising, Germany, the company operates a manufacturing facility in Thüringen. PreciPoint offers a comprehensive range of products, including smart microscopes, x-y-stages, electronic control systems, and automated testing systems. It also provides software solutions such as ViewPoint for virtual slide viewing and ScanPoint for whole slide scanning. By integrating laboratory information management software and AI-powered image analysis, PreciPoint enhances the capabilities of pathology labs, enabling them to deliver efficient and innovative diagnostic services. The company’s unique approach focuses on understanding laboratory workflows, facilitating improved outcomes in cancer diagnostics and pathology.

LifeGuides, PBC is a company based in Ocala, Florida, that specializes in providing stress consulting services tailored for employees facing various life challenges. Founded in 2016, LifeGuides offers an innovative Marketplace for Life Experience, featuring a community of trained and certified Guides who assist individuals in over 400 topics related to personal growth, lifelong learning, and everyday life events. These services are positioned as an HR benefit, enabling leading employers across diverse industries to support their employees' wellbeing. By connecting employees with experienced Guides who have successfully navigated similar life situations, LifeGuides fosters a unique environment of empathetic support. This approach not only enhances employee happiness but also promotes productivity, making it a valuable resource for organizations aiming to cultivate a positive workplace culture.